The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathway
Open Access
- 2 August 2016
- journal article
- research article
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 4 (3) , 338-349
Abstract
Introduction Chronic inflammatory diseases, such as rheumatoid arthritis and periodontitis, cause the bone destruction by promotion of the differentiation of monocyte/macrophage lineage cells into mature osteoclasts (OCs) with active bone‐resorbing character. However, the detailed mechanisms underlying this disorder remain unclear. We herein investigated the role of urokinase plasminogen activator receptor (uPAR) in the bone destruction caused by chronic inflammation. Methods We investigated that the effect of uPAR on inflammatory OC formation induced by lipopolysaccharide (LPS) in inflammatory diseases. Results We found that the LPS more weakly induced OC formation and the resultant bone loss in uPAR‐deficient mice than in wild‐type mice. Additionally, we demonstrated that uPAR significantly potentiated LPS‐induced OC formation of RAW264.7 mouse monocyte/macrophage linage cells in integrin β3/Akt‐dependent manner. Moreover, we showed that the blocking of uPAR function by the administration of anti‐uPAR neutralizing antibody significantly attenuated the LPS‐induced OC formation and the resultant bone loss in mice. Conclusions These results strongly suggest that uPAR negatively regulates the LPS‐induced inflammatory OC formation and the resultant bone loss mediated through the integrin β3/Akt pathway. Our findings partly clarify the molecular mechanisms underlying bone destruction caused by chronic inflammatory diseases, and would benefit research on identifying antibody therapy for the treatment of these diseases.Keywords
Funding Information
- JSPS KAKENHI Grants-in-Aid for Scientific Research (C: 25460078)
This publication has 44 references indexed in Scilit:
- Plasminogen/Plasmin Modulates Bone Metabolism by Regulating the Osteoblast and Osteoclast FunctionJournal of Biological Chemistry, 2011
- Urokinase-type plasminogen activator receptor is associated with the development of adipose tissueThrombosis and Haemostasis, 2010
- Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patientsJournal of Clinical Periodontology, 2009
- Post-Transcriptional Regulation of Urokinase-type Plasminogen Activator Receptor Expression in Lipopolysaccharide-induced Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cellsBiochemical and Biophysical Research Communications, 2007
- Molecular analysis of RANKL‐independent cell fusion of osteoclast‐like cells induced by TNF‐α, lipopolysaccharide, or peptidoglycanJournal of Cellular Biochemistry, 2006
- Osteoclast differentiation and activationNature, 2003
- Substrate Specificity of αvβ3Integrin-mediated Cell Migration and Phosphatidylinositol 3-Kinase/AKT Pathway ActivationJournal of Biological Chemistry, 2000
- Lipopolysaccharide antagonistsImmunology Today, 1992
- Identification of osteoclasts and their mononuclear precursors. A comparative histological and histochemical study in hamster periodontitisJournal of Periodontal Research, 1991